Clinical Trials Browser

Turcot syndrome × Neoadjuvant Therapy × Clear all

NCT03926338 2025-11-20

PICC

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT05913570 2023-06-22

MSI-H/dMMR

Phase 2 Unknown

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT05371197 2022-05-12

Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms